High Blood Pressure Linked to Mitral Regurgitation
|
By HospiMedica International staff writers Posted on 30 Oct 2017 |
A new study establishes a strong link between high blood pressure and mitral regurgitation, the most common heart valve disorder in high-income countries.
Researcher at the University of Oxford (United Kingdom), the University of Sydney (Australia), and other institutions affiliated with the George Institute for Global Health (Sydney, Australia) used linked electronic health records (EHRs) from the UK Clinical Practice Research Datalink (CPRD) from January 1, 1990, to December 31, 2015, in order to test the hypothesis that elevated systolic blood pressure (SBP) across its usual spectrum is associated with higher risk of mitral regurgitation.
The results revealed that of the 5,553,984 patients registered in the CPRD that met inclusion criteria, 28,655 (0.52%) were diagnosed with mitral regurgitation during the 10-year follow-up period, and a further 1,262 (0.02%) were diagnosed with mitral stenosis. SBP was continuously related to the risk of mitral regurgitation, with no evidence of a nadir down to 115 mmHg. Each 20 mmHg increment in SBP was associated with a 26% higher risk of mitral regurgitation. No link was identified between SBP and mitral stenosis.
Associations were similar for each 10 mmHg increment in diastolic blood pressure (DBP), or each 15 mmHg increment in pulse pressure (PP). The association was partially mediated by diseases affecting the left ventricle that resulted in secondary mitral regurgitation, such as myocardial infarction (MI, ischemic heart disease, cardiomyopathy, and heart failure (HF). However, the excess risk mediated by these causes was only 13%, with little effect on long-term association between SBP and mitral regurgitation. The study was published on October 17, 2017, in PLOS Medicine.
“With worldwide aging and population growth, we are likely to see an increasing number of cases of this condition. We need to find effective and affordable measures to tackle it, and our study suggests one possible avenue for prevention, by reducing high blood pressure,” said lead author Professor Kazem Rahimi, MD, PhD, deputy director of The George Institute UK. “Given the large and growing burden of mitral valve disease, particularly among older people, we believe these findings are likely to have significant implications for medical policy and practice around the world.”
There is a well-established association between hypertension and increased risk for stroke, coronary heart disease, and renal failure.javascript:newshowcontent('active','references'); Another common cardiovascular condition is atrial fibrillation (AF), the most common sustained cardiac arrhythmia, which is associated with a high mortality and morbidity rate from stroke, thromboembolism, and HF. Studies have shown that the risk of stroke doubles in patients with AF who also suffer from hypertension.
Related Links:
University of Oxford
University of Sydney
George Institute for Global Health
Researcher at the University of Oxford (United Kingdom), the University of Sydney (Australia), and other institutions affiliated with the George Institute for Global Health (Sydney, Australia) used linked electronic health records (EHRs) from the UK Clinical Practice Research Datalink (CPRD) from January 1, 1990, to December 31, 2015, in order to test the hypothesis that elevated systolic blood pressure (SBP) across its usual spectrum is associated with higher risk of mitral regurgitation.
The results revealed that of the 5,553,984 patients registered in the CPRD that met inclusion criteria, 28,655 (0.52%) were diagnosed with mitral regurgitation during the 10-year follow-up period, and a further 1,262 (0.02%) were diagnosed with mitral stenosis. SBP was continuously related to the risk of mitral regurgitation, with no evidence of a nadir down to 115 mmHg. Each 20 mmHg increment in SBP was associated with a 26% higher risk of mitral regurgitation. No link was identified between SBP and mitral stenosis.
Associations were similar for each 10 mmHg increment in diastolic blood pressure (DBP), or each 15 mmHg increment in pulse pressure (PP). The association was partially mediated by diseases affecting the left ventricle that resulted in secondary mitral regurgitation, such as myocardial infarction (MI, ischemic heart disease, cardiomyopathy, and heart failure (HF). However, the excess risk mediated by these causes was only 13%, with little effect on long-term association between SBP and mitral regurgitation. The study was published on October 17, 2017, in PLOS Medicine.
“With worldwide aging and population growth, we are likely to see an increasing number of cases of this condition. We need to find effective and affordable measures to tackle it, and our study suggests one possible avenue for prevention, by reducing high blood pressure,” said lead author Professor Kazem Rahimi, MD, PhD, deputy director of The George Institute UK. “Given the large and growing burden of mitral valve disease, particularly among older people, we believe these findings are likely to have significant implications for medical policy and practice around the world.”
There is a well-established association between hypertension and increased risk for stroke, coronary heart disease, and renal failure.javascript:newshowcontent('active','references'); Another common cardiovascular condition is atrial fibrillation (AF), the most common sustained cardiac arrhythmia, which is associated with a high mortality and morbidity rate from stroke, thromboembolism, and HF. Studies have shown that the risk of stroke doubles in patients with AF who also suffer from hypertension.
Related Links:
University of Oxford
University of Sydney
George Institute for Global Health
Latest Critical Care News
- Origami Robots to Deliver Medicine Less Invasively and More Effectively
- Improved Cough-Detection Technology Aids Health Monitoring
- AI Identifies Children in ER Likely to Develop Sepsis Within 48 Hours
- New Radiofrequency Therapy Slows Glioblastoma Growth
- Battery-Free Wireless Multi-Sensing Platform Revolutionizes Pressure Injury Detection
- Multimodal AI to Revolutionize Cardiovascular Disease Diagnosis and Treatment
- AI System Reveals Hidden Diagnostic Patterns in Electronic Health Records
- Highly Sensitive On-Skin Sensing Monitor Detects Vitamin B6 and Glucose in Sweat
- Artificial Intelligence Revolutionizing Pediatric Anesthesia Management
- New Device Detects Tuberculosis DNA Directly in Exhaled Air
- New Menstrual Cup Could Detect Infections and Improve Diagnostics
- Engineered “Natural Killer” Cells Could Help Fight Cancer
- Faster Lymph Flow Predicts Better Response to Diuretics in Acute Heart Failure
- New Global Recommendations Aim to End Deaths from Postpartum Hemorrhage
- 'Flat-Line ECG' Indicates Poor Outcomes for Out-Of-Hospital Cardiac Arrest
- New Guidance to Improve Diagnosis and Management of Heart Failure During Pregnancy and Postpartum
Channels
Surgical Techniques
view channel
Novel Glue Prevents Complications After Breast Cancer Surgery
Seroma and prolonged lymphorrhea are among the most common complications following axillary lymphadenectomy in breast cancer patients. These postoperative issues can delay recovery and postpone the start... Read more
Breakthrough Brain Implant Enables Safer and More Precise Drug Delivery
Delivering medication directly to specific regions of the brain has long been a major challenge in treating neurological disorders. Current implants and infusion systems typically reach only one or two... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more
CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more







.jpg)